CBL-514 COA: Identity, Purity and Content Explained
A useful CBL-514 certificate of analysis identifies the tested sample and reports clearly defined measurements. Identity, purity and content are different questions; one favorable result does not automatically answer all three.
Start with the reportβs scope
Match the reportβs sample identifier to the material being evaluated before looking at the largest percentage. Check the testing laboratory, date, method and reported units. If the sample cannot be linked to the supplied lot, the report may be informative without verifying that material.
NISTβs certificate definitions illustrate why a certificate needs a stated material, intended purpose, property values and relevant technical information.[1] This is general measurement context; it does not mean a DA vial is a NIST reference material.
Separate the three central questions
| Question | What the result must address |
|---|---|
| Identity | Whether the sample matches the claimed substance |
| Purity | The stated purity metric under the specified method |
| Content | How much of the measured analyte is present |
A chromatographic area percentage should not automatically be read as milligrams per vial. Likewise, a measured amount does not independently resolve every impurity or prove a biological effect. Ask the laboratory what the method can and cannot distinguish.
Evaluate the method against its purpose
ICH Q2(R2) addresses analytical procedure validation, including performance characteristics appropriate to the intended measurement.[2] The practical question is not simply whether a test was run, but whether the method supports the specific claim being made.
For your review, keep a short list of unresolved items: missing identity evidence, an unexplained purity calculation, absent content units or a lot mismatch. Request the missing information without rewriting the reportβs conclusions yourself.
The DA listing links researchers to the COA portal. This article does not assert a current CBL-514 purity result or completed test coverage. Use the actual matching report and confirm any gap with support. Analytical characterization also does not establish equivalence to Caliwayβs clinical formulation.
Frequently asked questions
Does 99% purity mean 19.8 mg in a 20 mg vial?
Not necessarily. That calculation assumes a purity basis and measured starting mass that the report may not establish.
Does a COA prove clinical effectiveness?
No. Analytical results characterize specified properties of a sample; they do not establish a human treatment outcome.
CBL-514 product and documentation
Review the current format and pack choices, then match the supplied lot to its documentation. No batch-specific identity, purity or content result is asserted in this article.
